I am actually impressed with how this traded today.... the Covid aspect was a bust, but thats what trials are for... what we are looking at now is for someone to come along and swoop this up. The clowns running this have no chance of surviving, but the product for OAK is real a mid size pharma would love to have it in my opinion. I think if we see continued buying over the next week or so we will get a price close to 75 or 80 cents a share on a buy out. With all of the averaging down there will be a lot of folks here who can make a profit.
News 
Market Data 
Discover 
